Generation of new sipanmycin analogues by combinatorial biosynthesis and mutasynthesis approaches relying on the substrate flexibility of key enzymes in the biosynthetic pathway.
The appearance of new infectious diseases, the increase of multi-resistant bacteria and the need for more effective chemotherapeutics have oriented the interests of researchers towards the search for metabolites with novel or improved bioactivities. Sipanmycins are disaccharyl glycosylated macrolactams that exert antibiotic and cytotoxic activities. By applying combinatorial biosynthesis and mutasynthesis approaches, we have generated eight new members of the sipanmycin family. The introduction of plasmids harboring genes responsible for the biosynthesis of several deoxysugars into the sipanmycin-producing strain Streptomyces sp. CS149 led to the production of six derivatives with altered glycosylation patterns. After structural elucidation of these new metabolites, we conclude that some of these sugars are the result of the combination of the enzymatic machinery coded by the introduced plasmids and the native enzymes of the D-sipanose biosynthetic pathway of the CS149 wild-type strain. In addition, two analogues of the parental compounds with a modified polyketide backbone were generated by a mutasynthesis approach, feeding cultures of a mutant strain defective in sipanmycin biosynthesis with 3-aminopentanoic acid. The generation of new sipanmycin analogues shown in this work relay on the substrate flexibility of key enzymes involved in sipanmycin biosynthesis, in particular the glycosyltransferase pair SipS9/SipS14 and enzymes SipL3, SipL1, SipL7 and SipL2 involved in the incorporation of the polyketide synthase starting unit.Importance Combinatorial biosynthesis has proven its usefulness in generating derivatives of already known compounds with novel or improved pharmacological properties. Sipanmycins are a family of glycosylated macrolactams produced by Streptomyces sp. CS149 whose antiproliferative activity is dependent on the sugar moieties attached to the aglycone. In this work, we report the generation of several sipanmycin analogues with different deoxysugars, showing the high degree of flexibility exerted by the glycosyltransferase machinery related to the recognition of diverse nucleotide-activated sugars. In addition, modifications in the macrolactam ring were introduced by mutasynthesis approaches, indicating that the enzymes involved in incorporating the starter unit have a moderate ability to introduce different types of β-amino acids. In conclusion, we have proven the substrate flexibility of key enzymes involved in sipanmycin biosynthesis, specially the glycosyltransferases, which can be exploited in future experiments.